Attached files
file | filename |
---|---|
EX-99.1 - EXHIBIT 99.1 - BIOHITECH GLOBAL, INC. | v464922_ex99-1.htm |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): April 24, 2017
BIOHITECH GLOBAL, INC.
(formerly known as Swift Start Corp.)
(Exact Name of Registrant as Specified in its Charter)
Delaware | 001-36843 | 46-233496 |
(State of Organization) | (Commission File Number) | (I.R.S. Employer |
Identification No.) |
80 Red Schoolhouse Road, Suite 101, Chestnut Ridge, NY 10977
(Address of principal executive offices)
Registrant’s telephone number, including area code: 845-262-1081
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Merger Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Merger Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Merger Act (17 CFR 240.13e-4(c))
Item 1.01. Entry Into a Material Definitive Agreement.
The information contained below in Item 8.01 is hereby incorporated by reference into this Item 1.01.
Item 8.01. Other Information.
As previously disclosed, BioHiTech Global, Inc. (the “Company”) entered into a Contract of Sale with the Town of New Windsor for the purchase of property located in New Windsor, New York. The purchase price of the property is $1,092,000, subject to reduction for option payments made by the Company in the monthly amount of $3,500 for the first 12 months and $6,000 per month for the following 12 months, until the closing. The purchase of the property is contingent upon the Company obtaining: necessary permits to allow construction of a Mechanical Biological Treatment (“MBT”) facility; approvals from state and local authorities; financing for the construction of the MBT facility; contracts for offtake of Solid Recovered Fuel; and the satisfaction of the Company’s due diligence investigation of the property. The contract also contains customary representations warranties and covenants of the parties for like transactions. A copy of the press release dated April 24, 2017, announcing the execution of the Contract of Sale, is attached to this Form 8-K as Exhibit 99.1 and incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d) | Exhibits |
99.1 | Press Release dated April 24, 2017 |
SIGNATURES
PURSUANT TO THE REQUIREMENTS OF THE SECURITIES EXCHANGE ACT OF 1934, THE REGISTRANT HAS DULY CAUSED THIS REPORT TO BE SIGNED ON ITS BEHALF BY THE UNDERSIGNED THEREUNTO DULY AUTHORIZED.
Date: April 24, 2017 | BIOHITECH GLOBAL, INC. | |
By: | /s/ Brian C. Essman | |
Name: Brian C. Essman | ||
Title: Chief Financial Officer and Treasurer |